band of 160,000 mol wt. Indirect immunofluorescence, using normal human skin as the substrate, indicated that IgG that was eluted from this protein band stained the epidermis in a cell surface pattern. PV sera did not specifically recognize any bands by immunoblot analysis. Immunoblots performed with PV antigen that was immunoprecipitated from cell culture extracts suggested that, once denatured for SDS-PAGE, PV antigen is no longer immunoreactive. Taken together, these data indicate that: autoantibodies contained in PV sera from various patients have a unique molecular specificity; autoantibodies from most PF sera have a specificity different from that of PV autoantibodies; and autoantibodies from various PF patients may not have identical antigenic specificities. These differences in antigenic specificity between PV and PF sera may account for the clinical and histologic differences between these diseases.
Introduction
Pemphigus is an autoimmune blistering disease of the skin. The histopathology of this disease demonstrates that blisters occur because of a loss of cell-to-cell adhesion, a process called acantholysis, which is presumably caused by autoantibodies (1) (2) (3) (4) (5) (6) (7) . There are at least two types of pemphigus, as defined by clinical and histologic criteria (1, 2) . Pemphigus vulgaris (PV), the most common type of pemphigus, is characterized by flaccid blisters and erosions in a generalized distribution, including the mucous membranes, which are almost always involved. Histopathology of PV lesions indicates acantholysis with the resultant blister formation deep in the epidermis, just above the basal layer. Pemphigus foliaceus (PF) is characterized by crusted and scaly lesions, which are commonly distributed on the scalp, face, upper chest, and back. Mucous membrane involvement is unusual. Histopathology of PF lesions demonstrates acantholysis and blister formation in the superficial epidermis, at the level of the granular layer.
In both PV and PF, biopsies from patients, when examined by direct immunofluorescence, demonstrate IgG on the cell surface of epidermal cells (1) (2) (3) . In addition, most patients with pemphigus have circulating antibodies (IgG) which bind the surface of cells in normal epidermis (or other stratified squamous epithelia), as detected by indirect immunofluorescence (1) (2) (3) .
Although a few patients with PF have been reported to have antibodies that bind only in the superficial epidermis, in general, antibodies from patients with PV and PF bind the cell surface of cells throughout the epidermis in patterns that are indistinguishable (8, 9) .
These autoantibodies are pathogenic in both PV and PF. PV IgG transferred to newborn mice causes the pathologic lesions of pemphigus (4) . In vitro models using organ culture of skin have demonstrated that PV or PF IgG, in the absence of complement or inflammatory cells, can cause acantholysis (5) (6) (7) . It is thought that the pemphigus IgG bound to the surface of the epidermal cell causes the release of one or more proteolytic enzymes, which results in acantholysis (7, (10) (11) (12) (13) (14) .
Although the importance of antibody binding to the epidermal cell surface in triggering the pathology of pemphigus has been well established, it is not known whether antibody binding to specific cell surface antigens is required to induce the specific pathology of PV or PF. Our recent studies demonstrated that most, but not all, pemphigus sera immunoprecipitate a glycoprotein synthesized by epidermal cells in culture (15) 15 jsg/ml epidermal growth factor, 5 gg/ml bovine insulin, 5 Ag/ml human transferrin, all from Sigma Chemical Co., and 10% fetal bovine serum (19, 20) . The cell layer was extracted, after radiolabeling, with 0.5% Nonidet P-40, as previously described (15) . This radiolabeled extract was used for immunoprecipitation experiments.
Immunoprecipitation. To identify and characterize newly synthesized pemphigus antigen in cultured cells, we used a protein A-immunoprecipitation technique that was previously described (15, 21) . In brief, after preabsorption with normal human serum and protein A-bearing staphylococci (Calbiochem-Behring Corp., San Diego, CA), an aliquot ofthe cell extract was incubated with 5 ,d ofeither pemphigus or normal sera (different from the one used in the preabsorption) at 4°C overnight. Protein A-bearing staphylococci were added to precipitate the antigen-antibody complexes. The pellet was washed six times with 0.3% Nonidet P-40, 0.3% sodium deoxycholate, 0.3 M NaCl in 10 mM Tris-HCI pH 7.4, and washed once with deionized H20. The precipitated, washed, antigen-antibody complexes were then solubilized by incubating at 100°C with gel sample buffer (2% SDS, 0.0625 M Tris-HCl, pH 6.8) with or without 0.1 M dithiothreitol for reduced and unreduced samples, respectively. Specifically precipitated antigens were then identified on SDS-PAGE (22) by fluorography (23, 24) using Enhance (New England Nuclear). Approximate molecular weights of immunoprecipitated molecules were determined on 5, 6, and 7.5% acrylamide gels by using either Coomassie Blue stained high molecular standards (Bio-Rad Laboratories, Richmond, CA) or '4C-labeled standards (New England Nuclear). Specific standards used were myosin, ,B-galactosidase, phosphorylase B, and bovine serum albumin.
Extraction of normal human epidermis and immunoblotting. To identify antigens that are present in normal human skin, we extracted suction blister-derived epidermis (from volar forearm) with gel sample buffer, as previously described (25) . The extracted proteins were separated by SDS-PAGE, then electrophoretically transferred to either nitrocellulose, as previously described (25, 26) , or to 2-aminophenylthioether (APT) paper (Bio-Rad Laboratories), which binds proteins covalently. Electrophoretic transfer to APT paper was performed according to the supplier's instructions. In short, paper was activated (diazotized) by incubation for 30 min at 4°C in a solution of 0.03% sodium nitrite in 1.2 M HCI. Electrophoretic transfer from gel to paper was then performed in 25 mM sodium phosphate buffer, pH 6.5, using a Trans-Blot cell (Bio-Rad Laboratories) at 50 V for 4-6 h. A cooling coil with recirculating water at 4°C was used for cooling during the transfer. After transfer, free protein binding sites were blocked by incubating the paper in 1% glycine in 0.15 M NaCI, 10 mM Tris-HCI, pH 7.4 (TBS) overnight at 4°C. Antigens on either nitrocellulose or APT paper were identified by immunoperoxidase staining, as previously described (25) . Pemphigus sera (and normal human sera controls) were used in dilutions of 1:100-1:250.
Elution ofantibodies from immunoblots. To confirm that PF antibodies, which specifically bound to a 160,000-mol wt protein band on immunoblots, were actually pemphigus antibodies, we eluted the IgG from the protein that was covalently bound to the APT paper, and used the eluted antibodies for indirect immunofluorescence on normal human skin to demonstrate cell surface staining of the epidermis. A technique similar to that described by Olmsted (27) was used. 15 lanes of electrophoresed proteins extracted from suction blister epidermis were transferred to one sheet of APT paper. The first and last lanes were cut off (as vertical strips) and immunoperoxidase staining was performed to identify the PF antigen in these lanes. These two stained lanes were then used to locate the unstained PF antigen in the 13 lanes left on the APT paper. These unstained protein bands were cut out in a horizontal strip. Thus, the strip contained 13 bands of PF antigen. A control strip of the same width (from below the area where the PF antigen was located) was also cut out. Each of these two horizontal strips was then incubated at 4°C overnight with a PF serum (175) that was diluted 1:50 (total volume 2.5 ml/strip). The strips were washed two times with washing buffer (10 mM Tris-HCI, 0.25 M NaCl, 0.5% Nonidet P-40, pH 7.4) and three times with TBS. The bound antibodies were then eluted twice with 0.5 M acetic acid, 0.5 M NaCl, pH 2.5 (total volume 5.0 ml/strip). Each elution was for 15 min at room temperature. The eluted antibodies were neutralized immediately using 2 M Tris-HCI, pH 8.5, 1.1 ml for each 2.5 ml of eluant. After elution the horizontal strips were washed with 3% bovine serum albumin in washing buffer and with 10% normal goat serum in TBS, and the antibody binding and elution were repeated. The eluted, neutralized antibodies were dialyzed against phosphate-buffered saline and concentrated on an Amicon PM-I0 filter (Amicon Corp., Lexington, MA) to -1.5 ml. Bovine serum albumin and sodium azide were added to a concentration of 0.1 and 0.02%, respectively, and the antibodies were further concentrated on a Minicon B1 5 unit (Amicon Corp.) to -100 ,l. These antibodies were then used for indirect immunofluorescence.
Results
Different PV sera immunoprecipitate the same glycoproteinfrom extracts of human epidermal cell culture. In order to identify PV antigen that was extracted from cultured human epidermal cells, we used sera from 12 patients with PV in immunoprecipitation assays. Proteins synthesized by human epidermal cells in culture were radiolabeled with '4C-amino acids, and immunoprecipitated proteins were identified by SDS-PAGE and fluorography (to visualize radiolabeled proteins). All 12 PV sera precipitated a protein which, when reduced, had chains of -130,000 and 80,000 mol wt ( Fig. 1 shows seven of these PV sera). The 80,000-mol wt band often appeared as a doublet with the slightly higher molecular weight band being the more intense. The specificity of this immunoprecipitation by PV sera is demonstrated by the finding that none of the 11 normal human sera, used concurrently with the PV sera in various immunoprecipitation experiments, precipitated these chains ( Other bands that were seen on this fluorograph were precipitated by both PV serum and N serum, and therefore are considered to be nonspecific. The migration of molecular weight markers is indicated on the right. kD, molecular weight X 10'.
cludes five of these normal sera). In addition, five bullous pemphigoid sera, used concurrently with the PV sera in some experiments, did not precipitate these chains. If the immunoprecipitates were electrophoresed unreduced, a protein of -210,000 mol wt was demonstrated by SDS-PAGE (Fig. 2) . This 210,000-mol wt molecule was precipitated by all of the four different PV sera tested under nonreducing conditions. These findings suggest that PV antigen consists of two chains of 130,000 and 80,000 mol wt, which are disulfide bonded in a 210,000-mol wt molecule. The co-migration, under reducing conditions, ofthe 130,000-mol wt bands and the 80,000-mol wt doublets, and, under nonreducing conditions, of the 2 10,000-mol wt bands that were precipitated by different PV sera, strongly suggest that autoantibodies in PV sera from different patients bind the same molecule. Additional evidence for the common molecular specificity ofdifferent PV sera was obtained by performing sequential immunoprecipitation with different PV sera (Fig. 3) .
We have previously demonstrated that, if '4C-glucosamine is used to label human epidermal cell cultures, most pemphigus sera precipitate a molecule with a 130,000-mol wt chain, under reducing conditions (15) . We also demonstrated that this chain was a glycoprotein, and that different pemphigus sera which reacted with this chain were directed against the same molecule. with either '4C-glucosamine or "Camino acids were performed, starting with equal amounts of radioactivity. The 130,000-mol wt band (arrow) of PV antigen labeled well with both, whereas the 80,000-mol wt band (arrowhead) did not label with '4C-glucosamine. The findings demonstrate that the 1 30,000-mol wt chain is heavily glycosylated compared with the 80,000-mol wt chain. Normal (N) serum is used as a control to demonstrate that the PV chains which are indicated are specifically precipitated. kD, molecular weight X 10-3.
To show that the 130,000-mol wt chain seen in the present experiments, which used '4C-amino acids as the label, was the same as the 130,000-mol wt chain in experiments using '4C-glucosamine as the label, we radiolabeled identical cultures with either '4C-amino acids or '4C-glucosamine. Starting with equal amounts of radioactivity, we immunoprecipitated both extracts with the same PV sera. Fig. 4 shows that the 130,000-mol wt chain is specifically precipitated using both extracts, but that the 80,000-mol wt band does not label well with '4C-glucosamine. This finding suggests that the 130,000-mol wt chain is more heavily glycosylated than the 80,000-mol wt chain. When the immunoprecipitates were electrophoresed unreduced (not shown), the 2 10,000-mol wt glycoprotein was labeled with both '4C-amino acids and '4C-glucosamine, but it was labeled less well with '4C-glucosamine. This finding is consistent with the assumption that the 2 10,000-mol wt molecule consists of the highly glycosylated 1 30,000-mol wt protein and the poorly glycosylated 80,000-mol wt protein.
Most PV and PF sera demonstrate different major antigenic specificities. We next wanted to determine whether antibodies from PF sera had the same antigenic specificity as the PV sera. Sera from eight patients with PF were tested, concurrent with PV sera, in the immunoprecipitation assay described above. Whereas all 12 PV sera that were tested consistently precipitated the 1 30,000-mol wt and 80,000-mol wt chains from extracts of '4C-amino acid-labeled human epidermal cell cultures, only one of the eight PF sera precipitated these chains. (Fig. 5 shows a typical experiment in which two PV sera precipitate these chains whereas two PF sera do not.) Sequential immunoprecipitation confirmed that the one exceptional PF serum (275) actually precipitated the PV antigen (Fig. 6) . The other seven PF sera did not precipitate the PV antigen or any other detectable specific molecules, even if the human epidermal cells are induced to more fully differentiate by depletion of the vitamin A from the fetal bovine serum that was used in the culture medium (19, 20) . These results demonstrate that whereas PV sera from different patients share antigenic specificity and define a specific glycoprotein that is synthesized by epidermal cells in culture, the PF sera tested, with one exception, do not share this particular antigenic specificity.
We next determined whether we could identify a molecule to which antibodies from PF sera would bind. Because we were unable to detect PF antigen in radiolabeled extracts of cultured human epidermal cells, we used extracts of normal human epidermis, which were derived from suction blisters, in an immunoblot assay to identify proteins that were reactive with PF autoantibodies. This procedure does not depend on synthesis and metabolic labeling in vitro. The extracted proteins were separated by SDS-PAGE (under reducing conditions), and were electrophoretically transferred to either nitrocellulose sheets or APT paper, which binds proteins covalently. The lanes ofprotein were then cut out and used for immunoperoxidase staining with PF sera. Four ofeight PF sera, including the one that precipitated the PV antigen from cultured cells, specifically stained a 160,000-mol wt protein (Fig. 7 shows three of these sera). All eight normal human sera that were tested, when used concurrently in various experiments, did not stain this band. In general, PV sera, tested concurrently, did not stain this 160,000-mol wt band (Fig. 7) , nor did they specifically stain any other band (see below). However, three of these nine PV sera inconsistently demonstrated an extremely faint staining of a band in the area of 160,000 mol wt ifthese sera were used at high concentrations -_ . N451 N451 PF275 PF275 PV86 PV86 Figure 6 . Sequential immunoprecipitation demonstrates that one exceptional PF serum (275) binds the same molecule as PV serum. (See legend Fig. 3 or if development in peroxidase substrate was extensive. The staining of these three PV sera was erratic from experiment to experiment, and was clearly different from the specific and intense staining seen with the PF sera. We did not consider the staining by these three PV sera as significant; however, it is possible that this faint staining may indicate a minor crossreactivity ofantibodies in some PV sera with the antigen defined by the PF sera.
To confirm that the PF antibodies that bound to the 160,000-mol wt protein were, in fact, pemphigus antibodies, we eluted the antibodies from the 160,000-mol wt protein that was covalently bound to APT paper. These eluted antibodies, when used for indirect immunofluorescence of normal human skin, displayed the typical cell surface staining of the epidermis that was seen with pemphigus antibodies (Fig. 8) . No cell surface staining was detected with a control eluate from an area of the same APT paper below the 160,000-mol wt band.
These results demonstrate that the autoantibodies in PF sera from different patients may have different antigenic specificities, but that at least some patients with PF have in common antibodies which bind a specific molecule that is extractable from normal human epidermis. These findings, taken together with the immunoprecipitation results, indicate that the major antigenic specificities of almost all PF and PV autoantibodies are distinct. The one exception was a PF serum that immunoprecipitated the PV antigen from extracts of cultured cells but that Figure 8 . Indirect immunofluorescence on normal human skin demonstrates that PF antibodies which bind the 160,000-mol wt protein band on immunoblots also bind the cell surface of epidermal cells. Extracts of normal human skin were electrophoresed by SDS-PAGE, then transferred to APT paper. The paper was subsequently incubated with PF serum, and the antibodies that bound to the 160,000-mol wt band were eluted. These antibodies were used for indirect immunofluorescence, and demonstrate the pattern of cell surface fluorescence that is normally seen with pemphigus sera. (x 460) also stained the 160,000-mol wt molecule on immunoblots. Whether this serum contained antibodies of different antigenic specificities or whether these antibodies were capable ofbinding both antigens is not known.
PV antigen cannot be identified by immunoblotting by using extracts ofeither normal human epidermis or human epidermal cell culture. To confirm that PV sera did not specifically stain any protein bands on immunoblots which used extracts of normal human epidermis, we attempted to detect PV antigen by immunoblotting using the following conditions: normal human epidermis was extracted with gel sample buffer or 0.5% Nonidet P-40 (which extracts PV antigen from cultured cells, as demonstrated by immunoprecipitation experiments); proteins were separated on 5, 7.5, and 5-12% gradient gels before transfer; and proteins were transferred to nitrocellulose or APT paper. In none of these situations were we able to detect PV antigen by immunoperoxidase staining of the transferred proteins.
In an attempt to determine why we were unable to detect PV antigen by immunoblot analysis of extracts of human epidermis, we investigated whether PV antigen that was immunoprecipitated from cell culture could be identified by immunoblot analysis. PV antigen, radiolabeled with '4C-amino acids, was immunoprecipitated from extracts of cultured human epidermal cells. This immunoprecipitate was run by SDS-PAGE in duplicate. Fluorography of the gel (Fig. 9 A) shows that PV antigen was present in the gel. The duplicate gel was then used for electrophoretic transfer of the PV antigen to nitrocellulose strips. Fluorography was performed on this gel after transfer, and the PV antigen was no longer detectable. This finding demonstrates that PV antigen can be transferred out of the gel. The transferred lanes of protein on nitrocellulose were used for immunoperoxidase staining with the same PV serum that was used to precipitate the antigen, and a normal human serum control was also used. No specific bands were stained (Fig. 9 B) . Then, in order to determine whether the PV antigen, which had transferred out of the gel, had actually bound to the nitrocellulose strips, we fluorographed the nitrocellulose strips. PV antigen was detected bound to the nitrocellulose (Fig. 9 C) (28) (29) (30) . These studies reported molecules of varying molecular weights, all lower than that of the antigen which we extracted from cultured cells. These disparate results may be due to several factors: (a) the type of pemphigus serum used to characterize the antigen was not defined (28) ; (b) different sources for extraction were used (e.g., saliva [28] , guinea pig skin [29] , human esophagus [30] ); (c) possible proteolytic breakdown during extensive chromatography procedures (28, 29) ; and (d) partial purification that resulted in a mixture of substances (29, 30) . The exact molecular nature of the PV antigen in vivo remains to be determined.
The different antigenic specificities between PV and PF antibodies demonstrated here has also been suggested by previous studies. Immunofluorescence blocking studies performed with sera from four patients with PV and two patients with Brazilian PF (a form of PF endemic to certain areas of Brazil) suggested that PV and PF antibodies bind different antigenic determinants (9) . In addition, the report that, by indirect immunofluorescence, some PF sera bound the epidermis in a different pattern than PV sera also, indicates that, at least for those PF sera, there may be an antigenic specificity different from that of PV sera (8) . However, antigenic masking may also account for different immunofluorescent patterns of identical antigens. In addition, most PF sera display the same pattern as PV sera in indirect immunofluorescence assays. The present study demonstrates that even if the PV and PF sera stain the epidermis in an indistinguishable pattern, they can have distinct antigenic specificities. We think it likely that the clinical and histologic differences between PV and PF are accounted for by the different cell surface antigens involved. Although the final common pathway for both diseases seems to be protease release which results in acantholysis (7), the antigen involved may, in a yet undefined way, influence the location of the blister in the epidermis.
Another explanation for the different clinical and histologic expression of PV and PF is that perhaps PF and PV antibodies have the same specificity, but the reactive antigen is missing in the deeper epidermis of patients with PF (31) . There is some experimental support, which is derived from indirect immunofluorescence studies on PF lesions, for this hypothesis (31) . However, the present study only found one PF serum that contained antibodies that were directed against PV antigen, and that serum also contained antibodies that were directed against an antigen defined by other PF sera. Thus, patients with PF who only have antibodies against PV antigen must be unusual, if they exist at all.
The identification and further characterization of specific antigens that are defined by PV and PF autoantibodies should help define the molecular basis ofthese diseases, and also should ultimately advance our understanding of the similarities and differences in their pathophysiology.
